AKTS smart money
Aktis Oncology, INC. (AKTS): 6 insider buys, 8 top funds holding it in the public filings.
Insider buys, 12 months$114.3M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-01-14 | Mpm Oncology Innovations Fund LP | TenPercentOwner | $20.0M | $18.0 |
| 2026-01-14 | Gadicke Ansbert | TenPercentOwner | $20.0M | $18.0 |
| 2026-01-14 | Foley Todd | Director,TenPercentOwner | $4.2M | $18.0 |
| 2026-01-12 | Nodelman Oleg | Director | $40.0M | $18.0 |
| 2026-01-12 | Vida Ventures II-A, LLC | TenPercentOwner | $15.0M | $18.0 |
| 2026-01-12 | Kim Helen Susan | Director,TenPercentOwner | $15.0M | $18.0 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 13 | Avidity Partners Management LP | 2.20% | $9M | |
| 19 | Tcg Crossover Management, LLC | TRIM -81% | 0.07% | $3M |
| 25 | Mpm Bioimpact LLC | 7.25% | $94M | |
| 31 | Affinity Asset Advisors, LLC | BUY | 0.40% | $7M |
| 46 | Sofinnova Investments, INC. | 0.03% | $600k | |
| 57 | Ecor1 Capital, LLC | 4.62% | $94M | |
| 71 | Baker Bros. Advisors LP | 0.09% | $19M | |
| 93 | Octagon Capital Advisors LP | TRIM -26% | 1.88% | $14M |